Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens

Little is known about the treatment of patients with hepatitis B surface antigen (HBsAg) recurrence after being clinically cured by peginterferon alpha(peg-IFN-α)-based regimens. This study aimed to investigate the efficacy and safety of peg-IFNα-2b in re-treating patients with HBsAg recurrence afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fengping, Wang, Yikai, Cui, Dandan, Tian, Yan, Lu, Rui, Liu, Chenrui, Li, Mei, Li, Yaping, Gao, Ning, Jiang, Zicheng, Li, Xuemei, Zhai, Song, Zhang, Xin, Jia, Xiaoli, Dang, Shuangsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821570/
https://www.ncbi.nlm.nih.gov/pubmed/36615161
http://dx.doi.org/10.3390/jcm12010361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821570/
https://www.ncbi.nlm.nih.gov/pubmed/36615161
http://dx.doi.org/10.3390/jcm12010361

Ejemplares similares